Back to Trades
Other4
LIGAND PHARMACEUTICALS INC
LGND
Total Value
$282.8K
Company Information
- Company Name
- LIGAND PHARMACEUTICALS INC
- Ticker Symbol
- LGND
- CIK
- 0000886163
Insider Information
- Name
- Aryeh Jason
- Role
- Director
- Location
- JUPITER, FL
Director
Filing Details
- Filing Date
- Dec 8, 2025
- Transaction Date
- Dec 8, 2025
- Accession Number
- 0002001011-25-000122
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Dec 8, 2025 | Common Stock | 2,034 | $69.51 | Exercise | $141.4K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Dec 8, 2025 | Derivative | 2,034 | $69.51 | Exercise | $141.4K |
Footnotes
- (F1)All securities disclosed in this Form 4 are owned by certain funds managed by JALAA Equities, LP, JLV Investments, LP and affiliates (the "Funds"). Jason Aryeh is the General Partner of JALAA Equities, LP and a partner of JLV Investments, LP. By reason of the provisions of Rule 16a-1 under the Securities Exchange Act of 1934, as amended, JALAA Equities, LP, JLV Investments, LP and affiliates and Mr. Aryeh may be deemed to be the beneficial owners of the securities beneficially owned by the Funds.
- (F2)This Option was previously reported as a Grant of 2,329 shares, which vested in full on May 23, 2016, at an exercise price of $119.3000 per share but was adjusted pursuant to the OmniAb Inc. separation from the issuer.